The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

Actinogen Medical (ASX:ACW) is developing a promising oral treatment for Alzheimer’s and depression and is accelerating clinical trials with new capital.

CEO Steven Gourlay, joins The Market Online to discuss the company’s development.

Join the discussion: See what HotCopper users are saying about Actinogen Medical Ltd and be part of the conversations that move the markets.

ACW by the numbers
More From The Market Online
Germanium crystals

Battery Age Minerals finds critical technology isotope Germanium-76 at Bleiberg

Battery Age Minerals has made a pivotal development in early-stage exploration of its Bleiberg mine in…
Man sits before earnings reports going crazy

Earnings wrap: Woodside, West African Gold, Bubs, and Pentanet

Let’s dive into an ASX speedrun this morning, looking at some earnings report takeaways and market reactions released on Wednesday.
Minas Gerais in Brazil

Viridis tips Colossus resource as best globally for MREOs

Viridis Mining and Minerals Ltd says its updated mineral resource estimate for the Brazilian project is…
Road in Namibia

‘Decades of future development opportunities’ ahead for Paladin after plant improvement works

Paladin Energy Ltd recorded uranium production broadly in line with yearly expectations, despite a fall back…